![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, April 30, 2020 8:55:47 AM
PRED'S lab is CLIA certified
https://www.fda.gov/media/137470/download
"I have concluded, pursuant to section 564(d)(1) of the Act, that the scope of this authorization is
limited to devices that meet the authorization criteria set forth below when used in laboratories
certified under CLIA, 42 U.S.C. 263a, to perform moderate or high complexity tests as an aid in
identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or
prior infection, by detecting antibodies (IgG, or IgG and IgM, or total), as specified in each
authorized device’s instructions for use, to SARS-CoV-2 in human plasma and/or serum during
the COVID-19 pandemic"
Manufacturers must submit clinical agreement data from an independent validation study
performed by the NCI, or by another government agency designated by FDA
RADM Denise M. Hinton
Chief Scientist
Food and Drug Administration
Maybacks Global Entertainment and ZEASN Technology Private Ltd. Sign Global Licensing Agreement • AHRO • Aug 8, 2024 7:00 AM
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results • SNWV • Aug 8, 2024 6:59 AM
Kona Gold Beverage Inc. Signs Letter of Intent with Bemax, Inc. to Sell Kona Gold, LLC • BMXC • Aug 7, 2024 10:00 AM
Btab Ecommerce Group, Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • BBTT • Aug 7, 2024 9:00 AM
Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update • HYDI • Aug 7, 2024 8:52 AM
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM